News
BARDA’s Division of Research, Innovation, and Ventures (DRIVe) has selected Jumpcode as a partner to develop a next-generation sequencing assay to diagnose respiratory viruses, including new and emerging pathogens. This technology could aid in detecting any pathogen on day one of a public health emergency, providing better preparation for future pandemics. Jumpcode has partnered with […]
Read MoreCRISPRclean® technology improves single cell transcriptional profiling, enabling scientists to discover and see signals that were previously obscured by abundant genomic sequences SAN DIEGO, Calif. – March 29, 2022 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced the launch of the CRISPRclean Single Cell RNA […]
Read MoreFeb 24, 2022 SAN DIEGO, Calif., Feb 24, 2022 /PRNewswire/– Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode’s CRISPRclean technology on Element’s AVITI System. The partnership has already demonstrated the value of pairing the technologies, promising improved data […]
Read MoreSeasoned finance and life sciences executive, Brandon Poe, joins rapidly growing team, supporting company growth SAN DIEGO, CA – November 17, 2021 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today that Brandon Poe has joined as Chief Financial Officer. Poe brings 25 years of financial […]
Read MoreJoin us at the ASHG 2021 Virtual Annual Meeting, October 18-22, 2021. If you’re registered, visit our partner page where you can find out about our latest products, talk to our experts, and learn about the innovative solutions we offer. Don’t forget to add the following events to your schedule: Platform presentation by Dr. Alden […]
Read More
